• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

94
53
37
36
28

COUNTRY

16
15
13
12
11

CATEGORIES

  • 188
  • 106
  • 65
  • 21
  • 14
  • 14
  • 14
  • 10
  • 8
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

77
179
240
369

PUBLISHED

3
8
103
369

PRODUCT TYPE

283
86

Search "Eli Lilly and Company - SWOT Analysis" returned 369 results.

PRODUCT TITLE
Eli Lilly & Co. Company Profile - Business Description, Strategies, SWOT and Financial Analysis Eli Lilly & Co. Company Profile - Business Description, Strategies, SWOT and Financial Analysis - Product Thumbnail Image

Eli Lilly & Co. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Eli Lilly & Co. Company Profile” is a comprehensive report on Eli Lilly & Co.. The report provides complete information on the operations, organization structure and financial information details of...

October 2014
FROM
Eli Lilly and Company - SWOT Framework Analysis Eli Lilly and Company - SWOT Framework Analysis - Product Thumbnail Image

Eli Lilly and Company - SWOT Framework Analysis

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective...

April 2013
FROM

Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review

Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2014
FROM

Eli Lilly and Company Market Share Analysis

Eli Lilly and Company Market Share Analysis Summary Our new report, “Eli Lilly and Company Market Share Analysis” provides in-depth information on Eli Lilly and Company's market position in the different...

September 2012
FROM

Eli Lilly and Company - SWOT, Strategy and Corporate Finance Report

Eli Lilly and Company - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

January 2013
FROM

Eli Lilly and Company - Strategy and SWOT Report

Eli Lilly and Company - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

May 2014
FROM
Analysis of Eli Lilly and Company Analysis of Eli Lilly and Company - Product Thumbnail Image

Analysis of Eli Lilly and Company

Analysis of Eli Lilly and Company. A complete and comprehensive analysis of Eli Lilly and Company, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry,...

January 2013
FROM

Psoriasis - Current and Future Players

Psoriasis - Current and Future Players Summary GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth...

May 2013
FROM
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis Lung Cancer Therapeutics Market Outlook and Pipeline Analysis - Product Thumbnail Image

Lung Cancer Therapeutics Market Outlook and Pipeline Analysis

With over 50% of all non-small cell lung cancer (NSCLC) patients diagnosed at the advanced stages of the disease, and 95% of all small-cell lung cancer (SCLC) patients unsuitable for surgical resection,...

November 2009
FROM
Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018 Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018 - Product Thumbnail Image

Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood CTC technology offers advantages like high sensitivity, high specificity,...

August 2012
FROM

PharmaPoint: Rheumatoid Arthritis - Current and Future Players

PharmaPoint: Rheumatoid Arthritis - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Rheumatoid Arthritis - Current and Future Players”. The report is a...

November 2012
FROM
Mexico Pharmaceutical Market Analysis, 2010-2014 Mexico Pharmaceutical Market Analysis, 2010-2014 - Product Thumbnail Image

Mexico Pharmaceutical Market Analysis, 2010-2014

Having displayed fluctuating growth rates in the years 2005-2009 the Mexico pharmaceuticals market is expected to stabilize in 2010 follow by the unchanged growth rates over the years up to 2014. The...

August 2010
FROM
Company Analysis - Merck & Co., Inc. Company Analysis - Merck & Co., Inc. - Product Thumbnail Image

Company Analysis - Merck & Co., Inc.

Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make...

January 2012
FROM

Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules

GBI Research, the leading business intelligence provider, has released its latest research “Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of...

January 2012
FROM

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

GBI Research, the leading business intelligence provider, has released its latest research, “Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs)...

October 2012
FROM

Global Molecular Diagnostics Market 2012-2016

TechNavio's analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11 42 percent over the period 2012-2016 One of the key factors contributing to this market growth is the increasing...

May 2013
FROM

Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market

GBI Research, the leading business intelligence provider, has released its latest research, “Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market”, which...

September 2011
FROM

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis....

November 2012
FROM
Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation - Product Thumbnail Image

Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation

The osteoporosis market is dominated by large pharmaceutical companies that can leverage their considerable financial reserves to conduct large-scale clinical trials, and which have the marketing strength...

November 2011
FROM

Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists

GBI Research, the leading business intelligence provider, has released its latest research ""Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia...

February 2012
FROM
Loading Indicator

Our Clients

Our clients' logos